INVO Bioscience, Inc. – NASDAQ:INVO
INVO Bioscience stock price monthly change
INVO Bioscience stock price quarterly change
INVO Bioscience stock price yearly change
INVO Bioscience key metrics
Market Cap | 3.25M |
Enterprise value | 7.99M |
P/E | -0.9 |
EV/Sales | 1.78 |
EV/EBITDA | -0.59 |
Price/Sales | 1.41 |
Price/Book | 4.91 |
PEG ratio | -0.04 |
EPS | -5.44 |
Revenue | 4.24M |
EBITDA | -5.05M |
Income | -7.08M |
Revenue Q/Q | 352.92% |
Revenue Y/Y | 321.66% |
Profit margin | -329.53% |
Oper. margin | -165.09% |
Gross margin | 91.6% |
EBIT margin | -165.09% |
EBITDA margin | -118.87% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeINVO Bioscience stock price history
INVO Bioscience stock forecast
INVO Bioscience financial statements
| Jun 2023 | 315.90K | -2.24M | -709.24% |
|---|---|---|---|
| Sep 2023 | 974.89K | -1.24M | -128.06% |
| Dec 2023 | 1.38M | -1.99M | -144.37% |
| Mar 2024 | 1.57M | -1.59M | -101.28% |
| Sep 2025 | 7.77M | 0 | |
|---|---|---|---|
| Oct 2025 | 7.77M | 0 | |
| Dec 2025 | 8.77M | 0 | |
| Dec 2025 | 8.77M | 0 |
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 6638894 | 8.34M | 125.69% |
|---|---|---|---|
| Sep 2023 | 19476171 | 19.10M | 98.09% |
| Dec 2023 | 20887787 | 19.99M | 95.73% |
| Mar 2024 | 18317765 | 18.30M | 99.94% |
| Jun 2023 | -1.64M | -261.50K | -169.85K |
|---|---|---|---|
| Sep 2023 | -1.24M | -2.25M | 4.44M |
| Dec 2023 | -714.88K | 33.29K | -141.52K |
| Mar 2024 | -260.55K | -24.10K | 527.36K |
INVO Bioscience alternative data
| Aug 2023 | 15 |
|---|---|
| Sep 2023 | 15 |
| Oct 2023 | 15 |
| Nov 2023 | 15 |
| Dec 2023 | 15 |
| Jan 2024 | 15 |
| Feb 2024 | 15 |
| Mar 2024 | 15 |
| Apr 2024 | 15 |
| May 2024 | 25 |
| Jun 2024 | 25 |
| Jul 2024 | 25 |
INVO Bioscience other data
| Period | Buy | Sel |
|---|---|---|
| Oct 2021 | 61348 | 0 |
| Jun 2022 | 354612 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | MESSINA REBECCA director: | Common Stock | 9,868 | $0.95 | $9,375 | ||
Purchase | GOREN ANDREA officer: Chief Financial Officer | Common Stock | 52,632 | $0.95 | $50,000 | ||
Purchase | CAMPBELL MICHAEL JOS. officer: Chief Op.. | Common Stock | 10,526 | $0.95 | $10,000 | ||
Purchase | SEGAL JEFFREY director: | Common Stock | 9,211 | $0.95 | $8,750 | ||
Purchase | SZOT MATTHEW K director: | Common Stock | 14,474 | $0.95 | $13,750 | ||
Purchase | DAVIS TRENT D director: | Common Stock | 11,184 | $0.95 | $10,625 | ||
Purchase | RYAN BARBARA director: | Common Stock | 10,526 | $0.95 | $10,000 | ||
Purchase | SHUM STEVE officer: Chief Executive Officer | Common Stock | 58,885 | $0.95 | $55,941 | ||
Purchase | DOODY KEVIN officer: Medical .. | Common Stock | 177,306 | $0.95 | $168,441 | ||
Purchase | SHUM STEVE director, officer: Chief Execut.. | Common Stock | 30,674 | $3.26 | $99,997 |
| Quarter | Transcript |
|---|---|
| Q2 2023 14 Aug 2023 | Q2 2023 Earnings Call Transcript |
| Q1 2023 15 May 2023 | Q1 2023 Earnings Call Transcript |
| Q4 2022 17 Apr 2023 | Q4 2022 Earnings Call Transcript |
| Q3 2022 14 Nov 2022 | Q3 2022 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
Mr. Steven M. Shum (1971) Chief Executive Officer & Director | $335,000 |
| Mr. Michael Jos. Campbell (1958) Chief Operating Officer & Vice President of Bus. Devel. | $305,620 |
| Dr. Kevin Doody M.D. (1959) Medical Director & Director | $25,000 |
-
When is INVO Bioscience's next earnings date?
Unfortunately, INVO Bioscience's (INVO) next earnings date is currently unknown.
-
Does INVO Bioscience pay dividends?
No, INVO Bioscience does not pay dividends.
-
How much money does INVO Bioscience make?
INVO Bioscience has a market capitalization of 3.25M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 267.38% to 3.02M US dollars.
-
What is INVO Bioscience's stock symbol?
INVO Bioscience, Inc. is traded on the NASDAQ under the ticker symbol "INVO".
-
What is INVO Bioscience's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of INVO Bioscience?
Shares of INVO Bioscience can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are INVO Bioscience's key executives?
INVO Bioscience's management team includes the following people:
- Mr. Steven M. Shum Chief Executive Officer & Director(age: 54, pay: $335,000)
- Mr. Michael Jos. Campbell Chief Operating Officer & Vice President of Bus. Devel.(age: 67, pay: $305,620)
- Dr. Kevin Doody M.D. Medical Director & Director(age: 66, pay: $25,000)
-
How many employees does INVO Bioscience have?
As Jul 2024, INVO Bioscience employs 25 workers, which is 67% more then previous quarter.
-
When INVO Bioscience went public?
INVO Bioscience, Inc. is publicly traded company for more then 4 years since IPO on 2 Nov 2020.
-
What is INVO Bioscience's official website?
The official website for INVO Bioscience is invobio.com.
-
Where are INVO Bioscience's headquarters?
INVO Bioscience is headquartered at 5582 Broadcast Court, Sarasota, FL.
-
How can i contact INVO Bioscience?
INVO Bioscience's mailing address is 5582 Broadcast Court, Sarasota, FL and company can be reached via phone at 978 878 9505.
INVO Bioscience company profile:
INVO Bioscience, Inc.
invobio.comNASDAQ
25
Medical - Devices
Healthcare
INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.
Sarasota, FL 34240
CIK: 0001417926
ISIN: US44984F4019
CUSIP: 44984F302
